TP53 and breast cancer: In males, when in heterozygosity, XRCC1 and TP53 variants seem to be related with lower susceptibility for BC, contrasting with high susceptibility for MUTYH. Overall, the differences found in XRCC1, MUTYH and TP53 polymorphisms may contribute to explain the significant difference in incidence of BC between the two sexes.